3Schwenke DC. Antioxidants and atherogenesis[J]. JNutr Biochem, 1998,9(8) :424.
4Cox DA, Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis [J].Pharmaco Rev, 1996,48(1) : 3.
5Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993,362(6) :801.
6Schwenke DC. Antioxidants and atherogenesis[J]. J Nutr Biochem, 1998,9(8) :424.
7Cox DA, Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation:clinical and pharmacological implications in atherosclerosis[J].Pharmaco Rev, 1996,48(1) : 3.
8Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993,362(6):801.
9Auestad.Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof[ P].United States Patent:6,495,599,2002-12-17.
10Hemelin.Nutritional supplements[ P].United States Patent:6,576,666,2003-06-10.
